Agenus Inc
Biotechnology
Healthcare
AGEN
21.55 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
5.06
52 week high
5.99
high
5.06
52 week low
1.51
previous Close
5.00
P/E ratio
-2
market cap
64.22 M
div yield
0
net incoming
-66.39 M
-25.07 %
net profit margin
-264.36 %
-38.00 %
operating incoming
-31.50 M
-4.34 %
net change in cash
-45.31 M
-210.86 %
cash on hand
44.78 M
-52.22 %
cost of revenue
41.20 M
35.00 %
top